"My experiences as a patient have only confirmed my confidence in what we do. It makes me super proud to work here," says survivor and employee Angela Harris. Read her story. #HealthCare #EndCancer
MD Anderson Cancer Center
Hospitals and Health Care
Houston, TX 225,001 followers
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer
About us
The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson provides cancer care at several convenient locations throughout the Greater Houston Area and collaborates with community hospitals and health systems nationwide through MD Anderson Cancer Network®. U.S. News & World Report's "Best Hospitals" survey has ranked MD Anderson the nation's top hospital for cancer care. Every year since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals. The recognition reflects the passion of our 21,000 extraordinary employees and 1,000 volunteers for providing exceptional care to our patients and their families, and for realizing our mission to #EndCancer. You can view all of our career opportunities at careers.mdanderson.org.
- Website
-
http://MDAnderson.org
External link for MD Anderson Cancer Center
- Industry
- Hospitals and Health Care
- Company size
- 10,001 employees
- Headquarters
- Houston, TX
- Type
- Educational
- Founded
- 1944
- Specialties
- Cancer, hospital, healthcare, oncology, research, doctor, health, wellness, medicine, education, education, science, health, clinical trials, nursing, cancer care, cancer research, training, fellowship, cancer education, cancer prevention, cancer treatment, and science and technology
Locations
Employees at MD Anderson Cancer Center
-
Guy Lipof
Data Science, AI, Executive, Healthcare & Life Sciences
-
Opral Wisham
QA Analyst V at Devon Energy
-
Ferran Prat Escude
Senior VP, Research Administration and Industry Relations at MD Anderson Cancer Center
-
Jake Lowry
Associate Professor of Comparative Medicine/Veterinarian at The University of Texas MD Anderson Cancer Center
Updates
-
Our physician assistants play a vital role in our mission to #EndCancer. We’re grateful for the quality, compassionate care they provide for our patients and their families today and every day. #PAWeek #Healthcare
-
In October, we wear pink. Visit https://brnw.ch/21wNsKS to find your look. #EndCancer
MD Anderson - Shop
shop.mdanderson.org
-
Recent research from MD Anderson features insights into metastases, novel targets for nerve pain, and a link between the gut microbiome and lung cancer. #CancerResearch #EndCancer
MD Anderson Research Highlights for October 2, 2024
mdanderson.org
-
It's time to dust off your boots and join us for MD Anderson's Boot Walk to End Cancer® on Saturday, Nov. 2. You can attend this year's event in person or join us virtually, from anywhere. Go to: MDAnderson.org/BootWalk to register. #EndCancer
-
We are pleased to welcome seven new members to the MD Anderson Cancer Center Board of Visitors, the institution’s nonfiduciary advisory board. “Our board members’ passion, expertise and insight propel us forward in our mission to end cancer," says MD Anderson president Dr. Peter Pisters. Learn about them here. #HealthCare #EndCancer
MD Anderson Board of Visitors celebrates growth and achievement
mdanderson.org
-
"MD Anderson is not just treating cancer – we are building a foundation for long-term, sustainable improvements in health care that will help generations to come," says our Dr. Kathleen Schmeler. Learn more about our efforts to end cancer around the world. #EndCancer
How MD Anderson’s global oncology commitment is improving cancer care worldwide
mdanderson.org
-
Starting tomorrow, experts from MD Anderson are presenting 48 abstracts at the 2024 American Society For Radiation Oncology (ASTRO) annual meeting. Learn more about some of the research that will be presented: https://bit.ly/3N4nVMU American Society for Radiation Oncology (ASTRO) #ASTRO24 #EndCancer
MD Anderson Research Highlights Special Edition: ASTRO 2024
mdanderson.org
-
A first-in-class antibody-drug conjugate works by targeting protein CD47, which helps immune cells activate and engulf cancer cells. The drug triggers an adaptive immune response to help eliminate the tumor. Learn more about the research, which Dr. Benjamin Schrank, MD PhD will present at the 2024 American Society for Radiation Oncology (ASTRO) conference. #EndCancer
Radiation therapy, the immune system and what’s ahead
mdanderson.org
-
The late Dr. Michael Frumovitz has been awarded the Julie and Ben Rogers Award for Excellence in Patient Care. During his more than 20 years of service to MD Anderson, Dr. Frumovitz was dedicated to MD Anderson’s mission to end cancer and demonstrated excellence in patient care. Read more. #EndCancer
Michael Frumovitz, M.D., posthumously honored with Julie and Ben Rogers Award for Excellence
mdanderson.org